Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosis

Benjamin T Kopp1, Sydney E Ross2, Dinesh Bojja1

  • 1Division of Pulmonology, Asthma, Cystic Fibrosis, and Sleep, Emory University School of Medicine, Atlanta, GA, USA; Children's Healthcare of Atlanta, Atlanta, GA, USA.

Insights

Nasal fluid analysis can detect airway inflammation in infants with cystic fibrosis (CF). Inflammatory markers like IL-6 and neutrophil elastase (NE) increase during viral infections and pulmonary exacerbations (PEx).

Area of Science:

  • Pediatric Pulmonology
  • Inflammatory Biomarkers
  • Cystic Fibrosis Research

Background:

  • Non-invasive detection of airway inflammation in infants with cystic fibrosis (CF) is challenging.
  • Inflammatory markers in nasal fluid were hypothesized to indicate inflammation during viral infections or pulmonary exacerbations (PEx).

Purpose of the Study:

  • To measure inflammatory markers (IL-1β, IL-6, IL-8, IL-10, IL-17A, neutrophil elastase (NE), TNF-α) in nasal fluid of infants with CF.
  • To assess if these markers correlate with viral infections, PEx, or environmental exposures like smoke.

Main Methods:

  • Collected nasal fluid, swabs, and hair from 34 infants with CF.
  • Analyzed nasal fluid for cytokines and nasal swabs for respiratory viruses.
  • Measured nicotine in hair samples and compared cytokine levels based on viral status, PEx, and smoke exposure.

Main Results:

  • Increased concentrations of IL-6, IL-8, TNF-α, and NE were observed in infants with respiratory viruses.
  • IL-17A decreased in infants with viral infections and PEx.
  • Elevated IL-6, IL-10, and NE levels were found in infants with detectable nicotine levels.

Conclusions:

  • Noninvasive nasal fluid collection is a viable method for identifying airway inflammation in infants with CF.
  • This approach can help monitor inflammation related to clinical changes and environmental exposures.
Abstract